TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
News  ›  GlobeNewswire Inc.

INSP CLASS ACTION DEADLINE: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Hagens Berman
INSP CLASS ACTION DEADLINE: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut

Inspire Medical Systems faces a securities class action lawsuit alleging executives misled investors about operational readiness for the Inspire V device launch. The company allegedly concealed critical failures including delayed Medicare billing software updates and excess inventory of the older Inspire IV device. The stock dropped $42.04 (32.4%) after the company slashed 2025 EPS guidance by over 80%. The Lead Plaintiff deadline is January 5, 2026.

Insights
HLBAY   positive

Proactively making an unsolicited acquisition proposal with attractive terms, showing strategic interest in Avadel's assets

INSP   negative

Company faces securities fraud allegations for concealing operational failures in device launch, resulting in 32.4% stock decline, 80%+ EPS guidance cut, and class action lawsuit with January 5, 2026 deadline for lead plaintiff claims.

Keywords
#securities fraud #class action lawsuit #Inspire V device #Medicare billing software #inventory glut #operational failures #guidance cut #stock collapse

Tickers
INSP
← Prev: Deadline Alert: Jayud Global Logistics Limited (JYD) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit